Abstract: Male chronic pelvic pain is a clinical syndrome in the field of urology and andrology characterized by complex etiology and a significant negative impact on patients' quality of life.Its treatment options are numerous yet often yield uncertain results.To address these challenges,the American Urological Association released the 2025 Guideline "Diagnosis and Management of Male Chronic Pelvic Pain." This guideline proposes a more refined classification system:(1) chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS);and (2) chronic scrotal content pain (CSCP).Furthermore,it emphasizes the importance of differentiating these conditions from interstitial cystitis/bladder pain syndrome (IC/BPS) and identifying the presence of pelvic floor myalgia.The guideline systematically organizes all current treatment modalities based on evidence-based medicine,encompassing behavioral/non-pharmacological interventions,pharmacological therapies,physical treatments,and surgical procedures.Notably,it provides a detailed overview of several surgical options for CSCP.

Key words: male chronic pelvic pain, american urological association, guideline;interpretation